Feed morbidity-and-mortality-weekly-report-mmwr Morbidity and Mortality Weekly Report (MMWR)

Favorite IconMorbidity and Mortality Weekly Report (MMWR)

Link https://www.cdc.gov/mmwr/index.html
Feed http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Updated 2025-06-05 08:01
QuickStats: Percentage of Adults Aged ≥18 Years with Kidney Disease, by Age Group and Sex — National Health Interview Survey, United States, July–December 2020
This report describes the percentage of adults with kidney disease in the United States
Notes from the Field: First Reports of Locally Transmitted Seoul Hantavirus Infection — District of Columbia, May 2018–December 2018
This report describes initial reports of hantavirus infection in District of Columbia during 2018.
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–January 31, 2022
This report describes COVID-19 vaccination coverage between rural and urban counties.
Geospatial Transmission Hotspots of Recent HIV Infection — Malawi, October 2019–March 2020
This report describes an analysis of HIV infection data collected during surveillance in Malawi.
Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021
This report describes use of type 2 oral poliovirus vaccine to treat a poliovirus outbreak in Tajikistan.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromi
This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022
This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households.
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022
This report describes a recommendation for using a 4-month regimen for the treatment of drug-susceptible pulmonary tuberculosis.
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021
This report describes updated guidance on use of the Ebola vaccine.
QuickStats: Age-Adjusted Suicide Rates for Males and Females, by Race and Ethnicity — National Vital Statistics System, United States, 2000–2020
This report describes age-adjusted suicide rates for males and females in the U.S.
Erratum: Vol. 71, No. 3
MMWR erratum volume 71, number 3.
Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021
This report describes the NFL’s test-to-release COVID-19 mitigation strategy.
Changes in Suicide Rates — United States, 2019 and 2020
This report describes changes in U.S. suicide rates from 2019 to 2020.
Antigen Test Positivity After COVID-19 Isolation — Yukon-Kuskokwim Delta Region, Alaska, January–February 2022
This report describes the percentage of positive antigen test results following COVID-19 isolation.
Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
This report describes increases in emergency department visits for mental health conditions among adolescent females in 2020, 2021, and 2022.
Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
This report describes how overall pediatric emergency department visits decreased in 2020, 2021, and January 2022 compared with 2019 but COVID-19 visits predominated.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
This report describes changes in the 2022 child and adolescent immunization schedule.
Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention — New York City, November 18–December 20, 2021
This report describes an outbreak of the SARS-CoV-2 Omicron variant among people attending a convention in New York City.
Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention — New York City, November–December 2021
This report describes SARS-CoV-2 transmission at a large indoor convention among a highly vaccinated population.
SURVEILLANCE SUMMARIES: Assisted Reproductive Technology Surveillance — United States, 2018
CDC reports on assisted reproductive technology procedures performed in 2018.
Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit — Reykjavik, Iceland, July 2021
This report describes an outbreak of Delta variant aboard a U.S. Navy ship.
QuickStats: Death Rates Attributed to Excessive Cold or Hypothermia, by Urbanization Level and Sex — National Vital Statistics System, 2018–2020
This report describes death rates attributed to excessive cold or hypothermia.
Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022
This report describes increases in COVID-19 hospitalization rates among children and adolescents during Omicron, especially among children not yet eligible for vaccination.
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–Janu
This report describes maternal mRNA vaccine effectiveness against COVID-19 hospitalizations among infants under 6 months of age.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.
EARLY RELEASE: Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Period
This report describes how vaccine effectiveness against COVID-19–associated emergency department/urgent care visits and hospitalizations was higher after the third dose but decreased with time.
Preventive Dental Care and Oral Health of Children and Adolescents With and Without Heart Conditions — United States, 2016–2019
This report describes dental care rates among children with and without heart conditions.
Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data — United States, 2019
This report describes antibiotic prescribing rates in a peer comparison.
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants — United States, June 2021–January 2022
This report describes genomic surveillance sequencing of COVID-19 variants by jurisdiction.
QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Reported Being Tired Most Days or Every Day, by Age Group and Hours of Screen Time — National Health Interview Survey
This report describes tiredness among children and adolescents by age and screentime.
Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2012–2020
This report describes global progress towards rubella elimination.
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance —
This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021
This report describes face mask or respirator effectiveness in helping protect against COVID-19 infection.
QuickStats: Rates of Emergency Department Visits Related to Mental Health Disorders Among Adults Aged ≥18 Years, by Disorder Category — National Hospital Ambulatory Medical Care Survey, Unite
This report describes rates of emergency department visits related to mental health disorders.
Self-Rated Physical Health Among Working-Aged Adults Along the Rural-Urban Continuum — United States, 2021
This report describes self-reported physical health among adults in both rural and urban areas of the United States.
Erratum: Vol. 70, No. 51–52
MMWR erratum volume 70, number 51–52.
Notes from the Field: COVID-19 Vaccination Among Persons Living with Diagnosed HIV Infection — New York, October 2021
This report describes COVID-19 vaccination coverage among adults diagnosed with HIV infection.
COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity — United States, August 29–October 30, 2021
This report describes COVID-19 vaccination coverage by sexual orientation and gender identity.
Association Between Social Vulnerability and Rates of HIV Diagnoses Among Black Adults, by Selected Characteristics and Region of Residence — United States, 2018
This report describes social vulnerability and rates of HIV diagnoses among black adults.
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance — Los Angeles County, Califo
This report describes COVID-19 incidence and hospitalization rates during Omicron predominance in January 2022.
QuickStats: Percentage of Adults Aged ≥18 Years with Diagnosed Diabetes, by Disability Status and Age Group — National Health Interview Survey, United States, 2020
This report describes the percentage of adults with diabetes by disability status and age group.
Erratum: Vol. 71, No. 2
MMWR erratum volume 71, number 2.
Erratum: Vol. 71, No. 1
MMWR erratum volume 71, number 1.
Notes from the Field: Increased Incidence of Fentanyl-Related Deaths Involving Para-fluorofentanyl or Metonitazene — Knox County, Tennessee, November 2020–August 2021
This report describes an increasing presence of para-fluorofentanyl in emergency department patients in Knox County, Tennessee..
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — Unit
This report describes the Advisory Committee on Immunization Practice recommendations for administering the pneumococcal conjugate vaccine to U.S. adults.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–Dece
This report describes the effectiveness of the third dose of Pfizer-BioNTech and Moderna vaccines in preventing hospitalizations.
Surveillance Summaries: Surveillance for Violent Deaths — National Violent Death Reporting System, 39 States, the District of Columbia, and Puerto Rico, 2018
This report provides a detailed summary of data from NVDRS on violent deaths that occurred in 2018.
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–Ja
This report describes disease severity and healthcare utilization during the emergence of the Omicron variant of the virus that causes COVID-19 in the U.S.
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, Ap
This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.
...16171819202122232425...